Prevalence and types of extended-spectrum β-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand

International Journal of Antimicrobial Agents

Volumn 34, Issue 6, 2009, Pages 544-549

  Heffernan, Helen M ^a   Woodhouse, Rosemary E ^a   Pope, Christopher E ^a   Blackmore, Timothy K ^b  

^a INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^b CAPITAL AND COAST DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

CTX M 15; CTX M 68; ESBLs; Escherichia coli; Klebsiella spp.; New Zealand

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; ESCHERICHIA COLI; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NEW ZEALAND; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; FEMALE; GENOTYPE; HUMANS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; NEW ZEALAND; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 70350396843     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.07.014     Document Type: Article

References (32)

1. Hirakata Y., Matsuda J., Miyazaki Y., Kamihira S., Kawakami S., Miyazawa Y., et al. Regional variation in the prevalence of extended-spectrum β-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn Microbiol Infect Dis 52 (2005) 323-329
2. Brett M. Extended-spectrum β-lactamases among urinary Escherichia coli and Klebsiella species in New Zealand in 2000 (2000), Institute of Environmental Science & Research, Porirua, New Zealand
3. Institute of Environmental Science & Research. Extended-spectrum β-lactamases (ESBLs) in Enterobacteriaceae confirmed in 2005. Porirua, New Zealand: ESR. http://www.surv.esr.cri.nz/PDF_surveillance/Antimicrobial/ESBL/ESBL_2005.pdf [accessed 11 August 2009].
4. Briggs S., Ussher J., and Taylor S. Extended-spectrum β-lactamase-producing Enterobacteriaceae at Middlemore Hospital. N Z Med J 118 (2005) U1563
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. Document M100-S16. Wayne, PA: CLSI; 2006.
6. Heffernan H., Woodhouse R., and Blackmore T. Methods used in New Zealand diagnostic laboratories to identify and report extended-spectrum β-lactamase-producing Enterobacteriaceae (2005), Institute of Environmental Science & Research, Porirua, New Zealand. http://www.surv.esr.cri.nz/PDF_surveillance/Antimicrobial/ESBL/ESBLMethods_2005.pdf Report No. FW0598. http://www.surv.esr.cri.nz/PDF_surveillance/Antimicrobial/ESBL/ESBLMethods_2005.pdf [accessed 11 August 2009]
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests; approved standard. 9th ed. Document M2-A9. Wayne, PA: CLSI; 2006.
8. Arpin C., Dubois V., Coulange L., André C., Fischer I., Noury P., et al. Extended-spectrum β-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob Agents Chemother 47 (2003) 3506-3514
9. De Gheldre Y., Avesani V., Berhin C., Delmée M., and Glupczynski Y. Evaluation of Oxoid combination discs for detection of extended-spectrum β-lactamases. J Antimicrob Chemother 52 (2003) 591-597
10. Saladin M., Cao V.T.B., Lambert T., Donay J.L., Herrmann J.L., Ould-Hocine Z., et al. Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett 209 (2002) 161-168
11. Jeong S.H., Bae I.K., Kwon S.B., Lee J.H., Song J.S., Jung H.I., et al. Dissemination of transferable CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli in Korea. J Appl Microbiol 98 (2005) 921-927
12. Costa D., Poeta P., Sáenz Y., Vinue L., Rojo-Bezares B., Jouini A., et al. Detection of Escherichia coli harbouring extended-spectrum β-lactamases of the CTX-M, TEM and SHV classes in faecal samples of wild animals in Portugal. J Antimicrob Chemother 58 (2006) 1311-1312
13. CTX-M within an Australian extended-spectrum β-lactamase gene pool. Antimicrob Agents Chemother 52 (2008) 4198-4202
14. Rossi F., Baquero F., Hsueh P.R., Paterson D.L., Bochicchio G.V., Snyder T.A., et al. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother 58 (2006) 205-210
15. European Antimicrobial Resistance Surveillance System (EARSS). Annual report 2006. http://www.rivm.nl/earss/result/Monitoring_reports/Annual_reports.jsp [accessed 11 August 2009].
16. Canton R., and Coque T.M. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 9 (2006) 466-475
17. Rossolini G.M., D'Andrea M.M., and Mugnaioli C. The spread of CTX-M-type extended-spectrum β-lactamases. Clin Microbiol Infect 14 Suppl. 1 (2008) 33-41
18. Radice M., Power P., Di Conza J., and Gutkind G. Early dissemination of CTX-M-derived enzymes in South America. Antimicrob Agents Chemother 46 (2002) 602-603
19. Livermore D.M., and Hawkey P.M. CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother 56 (2005) 451-454
20. Lavigne J.P., Marchandin H., Delmas J., Moreau J., Bouziges N., Lecaillon E., et al. CTX-M β-lactamase-producing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors. J Clin Microbiol 45 (2007) 620-626
21. Pitout J.D.D., Church D.L., Gregson D.B., Chow B.L., McCracken M., Mulvey M.R., et al. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob Agents Chemother 51 (2007) 1281-1286
22. Ensor V.M., Shahid M., Evans J.T., and Hawkey P.M. Occurrence, prevalence and genetic environment of CTX-M β-lactamases in Enterobacteriaceae from Indian hospitals. J Antimicrob Chemother 58 (2006) 1260-1263
23. Hawkey P.M. Prevalence and clonality of extended-spectrum β-lactamases in Asia. Clin Microbiol Infect 14 Suppl. 1 (2008) 159-165
24. Pitout J.D.D., Nordmann P., Laupland K.B., and Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 56 (2005) 52-59
25. Pitout J.D.D., and Laupland K.B. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8 (2008) 159-166
26. Woodford N., Ward M.E., Kaufmann M.E., Turton J., Fagan E.J., James D., et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother 54 (2004) 735-743
27. Pitout J.D.D., Gregson D.B., Church D.L., Elsayed S., and Laupland K.B. Community-wide outbreaks of clonally related CTX-M-14 β-lactamase-producing Escherichia coli strains in the Calgary health region. J Clin Microbiol 43 (2005) 2844-2849
28. Rodriguez-Bano J., Navarro M.D., Romero L., Muniain M.A., de Cueto M., Rios M.J., et al. Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli in the CTX-M era: a new challenge. Clin Infect Dis 43 (2006) 1407-1414
29. Moor C.T., Roberts S.A., Simmons G., Briggs S., Morris A.J., Smith J., et al. Extended-spectrum β-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand. J Hosp Infect 68 (2008) 355-356
30. Upton A., Mohiuddin J., Bathgate T., Taylor S., Simmons G., Woodhouse R., et al. High prevalence of CTX-M-15 extended-spectrum β-lactamase among contacts of patients with shigellosis due to Shigella flexneri carrying CTX-M-15. J Antimicrob Chemother 60 (2007) 906-908
31. Freeman J.T., McBride S.J., Heffernan H., Bathgate T., Pope C., and Ellis-Pegler R.B. Community-onset genitourinary tract infection due to CTX-M-15-producing Escherichia coli among travellers to the Indian subcontinent in New Zealand. Clin Infect Dis 47 (2008) 689-692
32. Nicolas-Chanoine M.H., Blanco J., Leflon-Guibout V., Demarty R., Alonso M.P., Caniça M.M., et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61 (2008) 273-281